PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

New international technical committee ISO/TC 313 Packaging Machinery set up under Italian chairmanship

The new committee will be responsible for drawing up international standards for packaging plant and machinery. Andrea Malagoli, Vice Chairman of UCIMA, has been app...
Continue Reading →
News

Tjoapack partner with Veratrak to launch first live blockchain tool

Global contract packaging organisation (CPO), Tjoapack, has partnered with UK-based technology company, Veratrak, to establish the use of blockchain across the pharm...
Continue Reading →
News

PCI Announces Expansion of its Industry-Leading Cold Chain Infrastructure with Dedicated -40°C Facility

PCI Clinical Services purpose-built state-of-the-art Cold Chain facility opens in Rockford, IL Philadelphia, USA – August 29, 2018 PCI Pharma Services (PCI), a ...
Continue Reading →
News

Wasdell Group set to open new Ireland facility

The Wasdell Group (Wasdell), a leading outsourcing partner to companies in the pharmaceutical, medical device and clinical trials industries, is opening a new facili...
Continue Reading →
News

Brexit and the pharmaceutical industry: what happens if there’s no deal?

The pharmaceutical industry has voiced its increasing concerns about the possibility of no-deal Brexit when the UK leaves the EU in March next year, and what ef...
Continue Reading →
News

Abortion in England: legalising home medical abortion pills

The UK Government has decided to legalise home-use of early medical abortion pills in England. Under the change in legislation, women will be able to choose whether ...
Continue Reading →
News

Dompé’s Oxervate gets approval to treat neurotrophic keratitis in US

Italian biopharmaceutical company Dompé farmaceutici has secured approval from the US Food and Drug Administration (FDA) for the use of its Oxervate medicine to trea...
Continue Reading →
News

EU approves first CAR-T therapies

European regulators have approved Novartis’ Kymriah and Gilead’s Yescarta, enabling patients to access CAR-T therapies across the region for the first time. Kymriah ...
Continue Reading →
News

UK says firms should stockpile drugs in case of no-deal Brexit

The UK government has published advice in the event of no-deal with the European Union – including recommendations for the healthcare sector. The Department of Healt...
Continue Reading →
News

Middle East and Africa pharma economy to reach US $38.8bn by 2021

CPhI Middle East & Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government reforms to further increase local manufacturing...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026